ATX-01
- Generic Name
- ATX-01
- Drug Type
- Biotech
- Background
ATX-01 is an antimiR, a chemically modified antisense oligonucleotide, designed to target microRNA 23b (miR-23b).
Study of ATX-01 in Participants with DM1
- First Posted Date
- 2024-03-08
- Last Posted Date
- 2025-02-28
- Lead Sponsor
- ARTHEx Biotech S.L.
- Target Recruit Count
- 56
- Registration Number
- NCT06300307
- Locations
- 🇺🇸
University of Florida, Gainesville, Florida, United States
🇺🇸University of Kansas Medical Center, Department of Neurology, Fairway, Kansas, United States
🇺🇸Virginia Commonwealth University, Richmond, Virginia, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath